SPDR S&P Biotech ETF (NYSEARCA:XBI) Reaches New 12-Month High – Should You Buy?

SPDR S&P Biotech ETF (NYSEARCA:XBI)’s share price hit a new 52-week high during trading on Tuesday . The stock traded as high as $146.77 and last traded at $145.86, with a volume of 16686026 shares trading hands. The stock had previously closed at $140.72.

SPDR S&P Biotech ETF Price Performance

The firm has a fifty day moving average of $134.55 and a two-hundred day moving average of $128.31. The stock has a market capitalization of $9.55 billion, a P/E ratio of 11.47 and a beta of 0.85.

Institutional Investors Weigh In On SPDR S&P Biotech ETF

Several large investors have recently modified their holdings of XBI. Compound Planning Inc. lifted its position in shares of SPDR S&P Biotech ETF by 0.7% in the 1st quarter. Compound Planning Inc. now owns 10,889 shares of the exchange traded fund’s stock worth $1,391,000 after purchasing an additional 75 shares during the period. Dynamic Wealth Strategies LLC increased its holdings in SPDR S&P Biotech ETF by 3.8% during the fourth quarter. Dynamic Wealth Strategies LLC now owns 2,201 shares of the exchange traded fund’s stock valued at $268,000 after buying an additional 80 shares during the period. Capital Investment Advisory Services LLC increased its holdings in SPDR S&P Biotech ETF by 4.0% during the fourth quarter. Capital Investment Advisory Services LLC now owns 2,123 shares of the exchange traded fund’s stock valued at $259,000 after buying an additional 81 shares during the period. PeakShares LLC raised its stake in SPDR S&P Biotech ETF by 5.2% in the first quarter. PeakShares LLC now owns 1,684 shares of the exchange traded fund’s stock worth $215,000 after buying an additional 84 shares in the last quarter. Finally, Commerce Bank raised its stake in SPDR S&P Biotech ETF by 2.8% in the fourth quarter. Commerce Bank now owns 3,260 shares of the exchange traded fund’s stock worth $397,000 after buying an additional 90 shares in the last quarter.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.